THE APEX TIMES
AI selloff cools, and chip rebounds carry Monday’s market back toward risk appetite
Broadcom, Corning, Micron and Eli Lilly were among the biggest movers as investors weighed whether Friday’s slide was a reset or the start of a deeper pullback.
U.S. stocks moved higher on Monday, June 8, 2026, after Friday’s sharp selloff in AI-linked equities left many chip and infrastructure names trading at low levels for the start of the week. Reuters reported that S&P 500 and Nasdaq 100 e-minis climbed in early trading as chip stocks “steadied” after dropping to over two-week lows, while renewed strikes in the Middle East kept investors cautious. The rebound helped shift focus from price momentum toward near-term catalysts across semiconductors, data center supply chains and even pharmaceuticals.
The broader selloff that preceded Monday’s bounce was linked to worries about whether expectations for AI growth had become too aggressive. In a Reuters report on Friday, U.S.-listed chipmakers lost more than $1 trillion in market value, with the PHLX semiconductor index down almost 8.5% in afternoon trading. Reuters also tied the shock to weak demand indicates after Broadcom posted results earlier in the week that showed demand for its custom AI chips business falling short of lofty expectations. Broadcom fell 7.5% on Friday, and Nvidia, Micron Technology and AMD posted steep declines as well.
On Monday, chip stocks largely reversed course in premarket trading, according to Reuters. Shares of Nvidia, Broadcom and Micron Technology rose between 1.5% and 3.9% before the open, rebounding from Friday’s drop. Reuters said expectations of tighter monetary policy and “underwhelming results from Broadcom last week” had raised concerns that the sector was growing too fast, prompting traders to pull back after a strong run in 2026. Strategists at UBS Global Wealth Management were quoted emphasizing that investors did not expect a loss of confidence in the AI outlook even as tech expectations faced scrutiny.
The rebound also reflected company-specific drivers outside pure AI-chip demand. An AP report said Micron Technology rose sharply on Monday after sliding 13.3% on Friday, and Marvell Technology climbed following its first trading day after S&P Dow Jones Indices said it had gained enough to join the widely followed S&P 500. AP characterized the broader theme as a market trying to determine whether Friday’s drop marked the beginning of a downturn or a pause that shakes out excessive optimism, with price action in chip and memory stocks acting as the clearest barometer.
Corning, a supplier of optical components used in high-capacity communications, gained ground on Monday after news tied it more directly to data center buildouts. AP reported Corning climbed 6.2% after Amazon announced a multibillion-dollar deal in which Corning will produce optical fiber, cable and other products for Amazon data centers across the United States. For investors, the move suggested incremental confidence that the optical and connectivity supply chain remains a beneficiary of AI infrastructure spending even as parts of the semiconductor market cool.
Eli Lilly was the outlier on the day’s “stocks explaining the tape” list, rising on a development unrelated to semiconductors. Reuters said Eli Lilly shares jumped 4.1% after trial results for retatrutide, an investigational next-generation obesity drug, showed improvements beyond weight loss. Reuters reported the study found retatrutide helped curb sleep apnea severity and also eased knee pain, at least in the reported trial outcomes. The reaction underscored how, when markets de-risk, investors often look for narrative support from major clinical data as well as from AI-adjacent industrial demand.
Broadcom entered Monday’s trading with extra sensitivity to expectations, even beyond market-wide rate worries. Broadcom describes itself as a global technology company that designs and supplies semiconductor and infrastructure software solutions, with products spanning networking, broadband, cybersecurity and private and hybrid cloud infrastructure. In the Reuters reporting on Friday’s selloff, the key concern was not the company’s long-term position in AI infrastructure, but the near-term demand announcement reflected in its custom AI chips performance. What remained unclear from the reports was the magnitude and breakdown of the shortfall, as well as whether any incremental demand visibility was provided after Friday’s close. The next test for the market, according to Reuters, was Wednesday’s consumer price report for May, which could further influence expectations for Federal Reserve policy.
keyFacts
Why It Matters
- The rebound suggests investors were willing to buy back into parts of the AI supply chain after a sentiment reset, but it also highlights how fragile positioning can be when expectations get recalibrated.
- Broadcom remains a sentiment bellwether for AI infrastructure demand, even as it is not a pure “chip maker” in the classic sense, because its mix includes semiconductors and infrastructure software.
- Corning’s jump points to continued market focus on data center connectivity, even when investors question the pace of AI-chip growth.
- Eli Lilly’s move shows how, in a choppy tape, investors can rotate to major clinical catalysts outside tech when they seek reassurance.
Sources
Key Facts
- Friday’s chip selloff wiped out more than $1 trillion in market value for U.S.-traded chipmakers, according to Reuters.
- The PHLX semiconductor index fell almost 8.5% on Friday, with Broadcom, Nvidia, Micron Technology and AMD among the major decliners, Reuters reported.
- Reuters said Friday’s drop was amplified by a weak Broadcom report earlier in the week showing demand for its custom AI chips business falling short of expectations.
- On Monday premarket, Reuters reported Nvidia, Broadcom and Micron shares rose between 1.5% and 3.9%.
- AP reported Corning gained 6.2% after Amazon announced a multibillion-dollar deal for Corning to supply optical fiber, cable and related products for U.S. data centers.
- Reuters reported Eli Lilly rose 4.1% after trial results for retatrutide showed improvements in sleep apnea severity and weight loss, and easing of knee pain.
Technology Related
Jensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gains
A CEO message to investors in June has been replayed after Nvidia’s stock moved higher over the following months, alongside gains in a broader AI peer group. Analysts caution that short-term trading often reflects many forces beyond a single CEO comment.
AMD says it is expanding its AI infrastructure footprint in Saudi Arabia
The chip designer announced a new platform initiative in Saudi Arabia, while investors appeared focused on how quickly the move could translate into additional AI-related revenue. AMD shares were little changed in Monday premarket trading.
Nvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlations
A market-linked read of Nvidia’s stock behavior suggests its relationship with broader semiconductor moves has shifted, a change that can affect hedging, positioning, and how traders interpret near-term momentum.
Nvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AI
Nvidia is investing $3.5 billion in Taiwan-based MediaTek via convertible bonds, deepening an existing AI partnership. The move points to growing interest in deploying AI closer to devices, not just in data centers.
FTC and 22 states sue Amazon, alleging it manipulated online ad auctions
Regulators claim Amazon’s advertising technology inflated costs for advertisers, saying the alleged conduct led to more than $20 billion in overcharges for about 1.2 million advertisers.
Alphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source libraries
In an update to its Antigravity multi-agent framework, Google reports results spanning theoretical computer science benchmarks, cycle-accurate hardware emulation, and upstream performance contributions to widely used software libraries.
Nvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes says
A Wall Street executive argues that today’s AI funding is not the limiting factor. The bottleneck, he says, is the physical supply chain behind data centers, where power and copper wiring needs can outstrip available materials.
Broadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrative
Ahead of its next quarterly report, Broadcom is drawing attention from investors who are trying to separate short-term uncertainty from longer-term demand linked to artificial intelligence.
Palantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hype
In comments highlighted by Yahoo Finance, Palantir’s CEO argues that investors should separate durable, use-case-driven AI progress from speculative “token industrial complex” narratives.
FTC and 22 states sue Amazon, alleging inflated prices in online ads scheme
The Federal Trade Commission and a coalition of states filed a lawsuit accusing Amazon of misleading advertising customers and defrauding them through inflated ad pricing. Amazon has not been found liable, and the company’s response was not included in the announcement referenced by the reporting.